The EIR indicated that the audit has been closed for the plant.
Moneycontrol News
Dr Reddy's Laboratories share price gained more than 2 percent intraday Tuesday after the US Food and Drug Administration closed the audit of company's facility in the United Kingdom.
The pharma major informed exchanges that it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration, for API Mirfield Plant, United Kingdom.
The EIR indicated that the audit has been closed for the plant.
In September 2017, the US FDA had completed its audit of the plant and issued a Form 483 with three observations.
At 12:29 hours IST, the stock price was quoting at Rs 2,162.60, up Rs 28.75, or 1.35 percent on the BSE.